Efficacy and safety of PD1/PDL1 blockades versus docetaxel in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis

BACKGROUND: PD1/PDL1 blockade is a promising treatment for patients with non-small-cell lung cancer (NSCLC). Here, we employed meta-analysis to evaluate the efficacy and safety of PD1/PDL1 blockades for previously treated NSCLC patients. METHODS: Randomized clinical trials were retrieved by searchin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jixiang, Zhong, Yulan, Peng, Shanshan, Zhou, Xiangxiang, Gan, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284541/
https://www.ncbi.nlm.nih.gov/pubmed/30584321
http://dx.doi.org/10.2147/OTT.S181413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284541/
https://www.ncbi.nlm.nih.gov/pubmed/30584321
http://dx.doi.org/10.2147/OTT.S181413

Ejemplares similares